Asia Pacific Contrast Injector Market
시장 규모 (USD 10억)
연평균 성장률 : %
예측 기간 |
2021 –2028 |
시장 규모(기준 연도) |
USD 245.27 Million |
시장 규모(예측 연도) |
USD 405.67 Million |
연평균 성장률 |
|
주요 시장 플레이어 |
>아시아 태평양 대조제 주입기 시장, 제품별(주입기 시스템, 소모품 및 액세서리), 응용 분야별(방사선학, 중재적 방사선학 및 중재적 심장학), 모달리티별(듀얼 헤드, 싱글 헤드 및 주사기 없는 주입기), 디자인별(받침대 장착, 천장 장착 및 독립형). 최종 사용자별(병원, 진단 영상 센터, 외래 수술 센터 및 기타), 유통 채널별(직접 입찰 및 제3자 유통업체). 국가별(중국, 인도, 인도네시아, 필리핀 및 베트남) - 2028년까지의 산업 동향 및 예측
시장 분석 및 통찰력: 아시아 태평양 대조 주입기 시장
대조제 주입기 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 6.5%의 CAGR로 성장하고 있으며 2020년의 2억 4,527만 달러에서 2028년까지 4억 567만 달러에 도달할 것으로 예상한다고 분석합니다. 노령 인구의 증가와 1인당 소득 증가가 예측 기간 동안 시장 수요를 촉진한 주요 요인입니다.
의료 인프라의 발전과 진단 절차의 증가는 효과적으로 대조제 주입기 시장의 성장을 돕습니다. 그러나 접근성 부족과 장치와 관련된 높은 비용은 대조제 주입기 시장의 미래 성장을 방해할 수 있습니다. 주요 시장 참여자의 파트너십과 인수는 대조제 주입기 시장 성장의 기회로 작용합니다.
대조 주입기 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 포켓, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
아시아 태평양 대조제 주입기 시장 범위 및 시장 규모
콘트라스트 인젝터 시장은 제품, 응용 분야, 양식, 디자인, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- 제품 시장은 인젝터 시스템, 소모품 및 액세서리로 세분화됩니다. 2021년에는 진단 절차의 증가로 인해 인젝터 시스템이 시장을 지배하고 있습니다.
- 응용 프로그램을 기준으로 시장은 방사선학, 중재적 방사선학 및 중재적 심장학으로 세분화됩니다. 2021년에는 효과적이고 조기 질병 진단에 대한 환자의 강조가 커지면서 방사선학이 시장을 지배하고 있습니다.
- On the basis of modality the market is segmented into dual-head, single head and syringeless injectors. In 2021, dual-head segment is dominating the market due to its multi-purpose usage of injecting both saline solutions and contrast media using single device.
- On the basis of design the market is segmented into pedestal mounted, ceiling mounted and standalone. In 2021, pedestal mounted segment is dominating the market due to its movement friendly compact design.
- On the basis of end user the market is segmented into hospital, diagnostic imaging centers, ambulatory surgical centers and others. In 2021, hospital segment is dominating the market due to growing number of hospitals in low and middle income countries.
- On the basis of distribution channel, the Contrast injector market is segmented into direct tender and third party distributors. In 2021, direct tender segment is dominating the market because direct tender holds the largest market share along with highest CAGR because most of the service providers buy the devices from manufacturers, and it is noticed that revenue from direct sales is higher; so it is influential as well as growing in the market.
Contrast injector Market Country Level Analysis
The Contrast injector market is analyzed and market size information is provided by product, application, modality, design, end user and distribution channel.
The countries covered in the Contrast injector market report are the China, India, Indonesia, Philippines and Vietnam.
Injector systems segment in Asia-pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 owing to growing usage of contrast injector during diagnosis. China is leading country in the growth of the Asia-Pacific market due to growing geriatric population as well as technology advancement in healthcare sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing strategic activities by major market players to enhance the awareness for contrast injector, is boosting the market growth of contrast injector market.
콘트라스트 인젝터 시장은 또한 콘트라스트 인젝터 산업의 모든 국가별 성장에 대한 자세한 시장 분석을 제공합니다. 게다가 콘트라스트 인젝터 판매, 규제 시나리오의 영향, 콘트라스트 인젝터 시장과 관련된 추세 매개변수에 대한 자세한 정보를 제공합니다. 이 데이터는 2011년부터 2019년까지의 과거 기간에 대한 것입니다.
경쟁 환경 및 대조 주입기 시장 점유율 분석
대조제 주입기 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 제공된 위의 데이터 포인트는 대조제 주입기 시장과 관련된 회사의 초점에만 관련이 있습니다.
Contrast injector를 취급하는 주요 회사는 다음과 같습니다.
Bayer AG, Guerbet, Bracco Imaging SpA, MEDTRON AG, Ulrich GmbH & Co.KG, Nemoto Kyrindo Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Shenzhen Anke High-tech Co. Ltd., SINO MDTBaslan Ltd., AADCO Medical Inc., SCW Medicath Ltd., B. Braun Melsungen Ag, Medline Industries Inc., Shenzhan Antmed Co., Ltd., Sinton Medical Products, Radtech X-Ray, Inc., Metron Healthcare, Angiodynamics Inc. 등이 있습니다.
또한 전 세계 여러 회사에서 많은 계약과 협정이 체결되면서 조영제 주입기 시장도 활성화되고 있습니다.
예를 들어,
- 2019년 9월, Bayer AG는 Medrad Stellant Flex CT 주입 시스템을 출시했습니다. Stellant Flex는 최소한의 기술자 교육과 자동화가 필요한 사용자 중심 시스템입니다. 회사의 TechCare 프로그램을 통해 자본 장비에 대한 유연한 옵션과 함께 개별화된 환자 프로토콜과 개인화된 이미징을 제공합니다.
- 2020년 3월, ulrich medical은 미국 시장을 위해 설계된 CT 모션 대조 매체 주입기 버전을 발표했습니다. FDA 승인을 받았으며 파트너인 GE Healthcare와 협력하여 마케팅될 예정입니다. ulrich medical은 이미 60개국 이상에 대조 매체 주입기를 공급하고 있습니다. 이 제품 출시로 회사의 기존 대조 주입기 장치와 제품 포트폴리오가 강화되었고 시장에서 수익성 있는 성장을 달성하는 데 도움이 되었습니다.
협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 조영제 주입기 시장에서 회사의 입지를 강화하고 있으며, 이는 조직의 수익 성장에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CONTRAST INJECTOR MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 COMPONENT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS
5.1 FOOD AND DRUG ADMINISTRATION GUIDELINES
5.2 EUROPEAN MEDICAL AGENCY REGULATION
5.3 REGULATION IN CHINA
6 REGIONAL SUMMARY
6.3 ASIA PACIFIC CONTRAST INJECTOR MARKET
6.3.1 OVERVIEW
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES SUCH AS CANCER AND CVD
7.1.2 GROWTH IN NUMBER OF IMAGING PROCEDURES
7.1.3 INCREASING PRODUCT APPROVAL
7.1.4 REIMBURSEMENT POLICY FOR CONTRAST MEDIA
7.2 RESTRAINTS
7.2.1 CHANGING END USER DEMAND
7.2.2 HIGH COST OF CONTRAST INJECTOR SYSTEMS
7.2.3 RISKS ASSOCIATED WITH THE USE OF CONTRAST MEDIA IN THE INJECTOR SYSTEM
7.2.4 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE
7.3.2 ADVANCEMENT IN TECHNOLOGY
7.3.3 COLLABORATIONS AND AGREEMENTS IN THE MARKET
7.4 CHALLENGES
7.4.1 ISSUES RELATED TO MEDICAL DEVICES HACKING
7.4.2 HIGH COST OF MRI AND CT SCAN MACHINE
7.5 IMPACT OF COVID-19 ON GLOBAL CONTRAST INJECTOR MARKET
7.6 IMPACT ON SUPPLY CHAIN
7.7 IMPACT ON DEMAND
7.8 PRICE IMPACT
7.9 STRATEGIC DECISIONS FOR MANUFACTURERS
7.1 CONCLUSION
8 CONTRAST INJECTOR MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INJECTOR SYSTEM
8.2.1 TYPE
8.2.2 CT INJECTOR
8.2.3 MRI INJECTOR
8.2.4 ANGIOGRAPHY INJECTOR
8.3 BY MODALITY
8.3.1 DUAL-HEAD
8.3.2 SINGLE HEAD
8.3.3 SYRINGELESS INJECTOR
8.4 CONSUMABLES
8.5 ACCESSORIES
9 CONTRAST INJECTOR MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 RADIOLOGY
9.2.1 INJECTOR SYSTEMS
9.2.2 CONSUMABLES
9.2.3 ACCESSORIES
9.3 INTERVENTIONAL RADIOLOGY
9.3.1 INJECTOR SYSTEMS
9.3.2 CONSUMABLES
9.3.3 ACCESSORIES
9.4 INTERVENTIONAL CARDIOLOGY
9.4.1 INJECTOR SYSTEMS
9.4.2 CONSUMABLES
9.4.3 ACCESSORIES
10 CONTRAST INJECTOR MARKET, BY MODALITY
10.1 OVERVIEW
10.2 DUAL-HEAD
10.3 SINGLE HEAD
10.4 SYRINGELESS INJECTORS
11 CONTRAST INJECTOR MARKET, BY DESIGN
11.1 OVERVIEW
11.2 PEDESTAL MOUNTED
11.3 CEILING MOUNTED
11.4 STANDALONE
12 CONTRAST INJECTOR MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 INJECTOR SYSTEMS
12.2.2 CONSUMABLES
12.2.3 ACCESSORIES
12.3 DIANGOSTIC IMAGING CENTERS
12.3.1 INJECTOR SYSTEMS
12.3.2 CONSUMABLES
12.3.3 ACCESSORIES
12.4 AMBULATORY SURGICAL CENTERS
12.4.1 INJECTOR SYSTEMS
12.4.2 CONSUMABLES
12.4.3 ACCESSORIES
12.5 OTHERS
13 CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
14 CONTRAST INJECTOR MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 INDIA
14.1.3 INDONESIA
14.1.4 PHILIPPINES
14.1.5 VIETNAM
15 CONTRAST INJECTOR MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 BAYER AG
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BRACCO IMAGING SPA
17.2.1 COMPANY SNAPSHOT
17.2.2 COMPANY SHARE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 GUERBET
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 NEMOTO KYORINDO CO., LTD
17.4.1 COMPANY SNAPSHOT
17.4.2 COMPANY SHARE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 ULRICH GMBH & CO.KG
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 MEDTRON AG
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 AADCO MEDICAL, INC.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANGIODYNAMICS
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 APOLLO RT CO.LTD
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 BASLAN LTD.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 B.BRAUN MELSUNGEN AG
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 MEDLINE INDUSTRIES, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 METRON HEALTHCARE
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 RADTECH X-RAY, INC.
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 SCW MEDICATH LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 SHENZHEN ANKE HIGH-TECH
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SHENZHEN ANTMED CO., LTD
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 SINO MDT
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 SINTON MEDICAL PRODUCT
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 YEARS)
TABLE 2 CONTRAST INJECTOR MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
TABLE 3 INJECTOR SYSTEM IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 6 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 7 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 8 CONSUMABLES IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ACCESSORIES IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 RADIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 18 DUAL-HEAD IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 SINGLE HEAD IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 SYRINGELESS INJECTORS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 22 PEDESTAL MOUNTED IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 CEILING MOUNTED IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 STANDALONE IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 HOSPITALS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 32 OTHERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 34 DIRECT TENDER IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 THIRD PARTY DISTRIBUTORS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY COUNTRY, 2019-2028 (USD MILLION )
TABLE 37 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 40 ASIA-PACIFIC INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 41 ASIA-PACIFIC INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 CHINA CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 54 CHINA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 CHINA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 56 CHINA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 57 CHINA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 58 CHINA CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 CHINA INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 61 CHINA INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 CHINA CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 63 CHINA CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 64 CHINA CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 CHINA HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 CHINA DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 CHINA AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 CHINA CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 69 INDIA CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 70 INDIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 71 INDIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 72 INDIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 73 INDIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 74 INDIA CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 INDIA RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 INDIA INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 INDIA INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 INDIA CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 79 INDIA CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 80 INDIA CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 81 INDIA HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 82 INDIA DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 INDIA AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 INDIA CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 INDONESIA CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 86 INDONESIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 87 INDONESIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 88 INDONESIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 89 INDONESIA INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 90 INDONESIA CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 INDONESIA RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 92 INDONESIA INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 93 INDONESIA INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 INDONESIA CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 95 INDONESIA CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 96 INDONESIA CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 97 INDONESIA HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 98 INDONESIA DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 INDONESIA AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 INDONESIA CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 PHILIPPINES CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 102 PHILIPPINES INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 103 PHILIPPINES INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 104 PHILIPPINES INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 105 PHILIPPINES INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 106 PHILIPPINES CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 PHILIPPINES RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 108 PHILIPPINES INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 PHILIPPINES INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 PHILIPPINES CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 111 PHILIPPINES CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 112 PHILIPPINES CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 113 PHILIPPINES HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 PHILIPPINES DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 PHILIPPINES AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 PHILIPPINES CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 VIETNAM CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 118 VIETNAM INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 VIETNAM INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 120 VIETNAM INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)
TABLE 121 VIETNAM INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 122 VIETNAM CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 VIETNAM RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 124 VIETNAM INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 125 VIETNAM INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 126 VIETNAM CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 127 VIETNAM CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)
TABLE 128 VIETNAM CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 129 VIETNAM HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 130 VIETNAM DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 VIETNAM AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 132 VIETNAM CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 CONTRAST INJECTOR MARKET: SEGMENTATION
FIGURE 2 CONTRAST INJECTOR MARKET: DATA TRIANGULATION
FIGURE 3 CONTRAST INJECTOR MARKET: DROC ANALYSIS
FIGURE 4 CONTRAST INJECTOR MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 CONTRAST INJECTOR MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CONTRAST INJECTOR MARKET: MULTIVARIATE MODELLING
FIGURE 7 CONTRAST INJECTOR MARKET: COMPONENT TYPE LIFELINE CURVE
FIGURE 8 CONTRAST INJECTOR MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 CONTRAST INJECTOR MARKET: DBMR MARKET POSITION GRID
FIGURE 10 CONTRAST INJECTOR MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 CONTRAST INJECTOR MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 12 CONTRAST INJECTOR MARKET: SEGMENTATION
FIGURE 13 U.S. IS EXPECTED TO DOMINATE THE CONTRAST INJECTOR MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INCREASING PREVALENCE OF CHRONIC DISEASES AND GROWTH IN NUMBER OF IMAGING PROCEDURES IS EXPECTED TO DRIVE THE GROWTH OF CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR THE CONTRAST INJECTOR MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF CONTRAST INJECTOR MARKET
FIGURE 18 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 19 IMAGING RATE IN U.S. (RATE PER 1000 PERSON/YEAR)
FIGURE 20 CONTRAST INJECTOR MARKET: BY PRODUCT , 2020
FIGURE 21 CONTRAST INJECTOR MARKET: BY PRODUCT , 2021-2028 (USD MILLION)
FIGURE 22 CONTRAST INJECTOR MARKET: BY PRODUCT , CAGR (2021-2028)
FIGURE 23 CONTRAST INJECTOR MARKET: BY PRODUCT , LIFELINE CURVE
FIGURE 24 CONTRAST INJECTOR MARKET: BY APPLICATION, 2020
FIGURE 25 CONTRAST INJECTOR MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 26 CONTRAST INJECTOR MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 27 CONTRAST INJECTOR MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 CONTRAST INJECTOR MARKET: BY MODALITY, 2020
FIGURE 29 CONTRAST INJECTOR MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 30 CONTRAST INJECTOR MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 31 CONTRAST INJECTOR MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 32 CONTRAST INJECTOR MARKET: BY DESIGN, 2020
FIGURE 33 CONTRAST INJECTOR MARKET: BY DESIGN, 2021-2028 (USD MILLION)
FIGURE 34 CONTRAST INJECTOR MARKET: BY DESIGN, CAGR (2021-2028)
FIGURE 35 CONTRAST INJECTOR MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 36 CONTRAST INJECTOR MARKET: BY END USER, 2020
FIGURE 37 CONTRAST INJECTOR MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 38 CONTRAST INJECTOR MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 CONTRAST INJECTOR MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 42 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC CONTRAST INJECTOR MARKET: SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC CONTRAST INJECTOR MARKET: BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC CONTRAST INJECTOR MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 ASIA-PACIFIC CONTRAST INJECTOR MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC CONTRAST INJECTOR MARKET: BY PRODUCT (2021-2028)
FIGURE 49 ASIA PACIFIC CONTRAST INJECTOR MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.